Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02211768
What this trial is testing

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Who this might be right for
NeurofibromatosisMPNST
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT04351035
What this trial is testing

National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry

Who this might be right for
Tumors, Central Nervous SystemPediatric Brain TumorMalignant Brain Tumor+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 4,303
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)WithdrawnNCT00053040
What this trial is testing

Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Not applicableLooking for participantsNCT05113017
What this trial is testing

The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)

Who this might be right for
The Efficacy and Safety of SBRT in MPLC
Fang Wu 40
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Early research (Phase 1)Looking for participantsNCT05629689
What this trial is testing

Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Who this might be right for
Malignant Solid TumorOncology
GE Healthcare 50
Very early researchUnknownNCT05239676
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Who this might be right for
Lymphoma
Zhejiang University 50
Not applicableStudy completedNCT01627990
What this trial is testing

Nivestim™ in Treatment of Malignant Diseases

Who this might be right for
Solid TumourMalignant Haematological TumourPrimary or Secondary Prophylactic Treatment
Hospira, now a wholly owned subsidiary of Pfizer 386
Not applicableStudy completedNCT04597710
What this trial is testing

Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing

Who this might be right for
Liver CancerLiver Metastasis Colon Cancer
Perspectum 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Not applicableUnknownNCT00899613
What this trial is testing

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
University Hospital, Caen 270
Early research (Phase 1)Study completedNCT01878890
What this trial is testing

Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.

Who this might be right for
Solid TumorsNon-Hodgkin's Lymphoma
Institut Bergonié 25
Not applicableActive Not RecruitingNCT02104310
What this trial is testing

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

Who this might be right for
Malignant Glioma
Mayo Clinic 25
Not applicableActive Not RecruitingNCT06198010
What this trial is testing

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 680
Not applicableLooking for participantsNCT06279013
What this trial is testing

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
NRG Oncology 600
Early research (Phase 1)Study completedNCT01404390
What this trial is testing

Japanese BAY80-6946 Monotherapy Phase I Study

Who this might be right for
Neoplasms
Bayer 10
Not applicableNot Yet RecruitingNCT07665697
What this trial is testing

Analysis of Efficacy and Outcomes of Immunotherapy for Malignant Tumors: A Prospective Non-interventional Clinical Study

Who this might be right for
NeoplasmsDrug TherapyImmune Checkpoint Inhibitors (ICIs)
Sichuan University 500
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00051597
What this trial is testing

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

Who this might be right for
Hodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more
Seagen Inc. 70
Next Page